Abeona Therapeutics Inc
ABEO
Market Cap$320.13M
Close$
$0.01
99.9% downside
Current Fair Value
99.9% downsideOvervalued by 99.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $320.13 Million |
|---|---|
| Enterprise Value | $319.82 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.55 |
| Beta | 1.7 |
| Outstanding Shares | 41,048,206 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.23 |
|---|---|
| PEG | 9.6 |
| Price to Sales | - |
| Price to Book Ratio | 5.49 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.57 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Abeona Therapeutics Inc
CEO: Joao Siffert